| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |